IFI16 facilitates the inflammatory endothelial pathophenotypes observed among individuals with PAH, according to new research ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

Endothelial inflammation, as measured by E-selectin, was significantly associated with hypoxemia measures, even after adjusting for BMI.

In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...

Squamous cell carcinoma of the lung (LUSC) stands as the second most prevalent form ... seen in patients with LUSC compared with those with nonsquamous NSCLC. Vascular endothelial growth factor (VEGF) ...

Aerosolized vascular endothelial growth factor/stromal cell-derived factor-1α (VEGFNP/SDFNP) led to a lower pulmonary arterial pressure and prevented right ventricular hypertrophy after ...

Gut microbiota-derived phenylacetylglutamine accelerates aging by driving cellular senescence through mitochondrial ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 35.6% in the past six months compared with the industry’s decline ...

Bevacizumab biosimilar is under clinical development by Curateq Biologics and currently in Phase I for Metastatic Colorectal Cancer.

non-squamous and non-small cell lung cancer. It is administered through intravenous route. The drug candidate acts by targeting the human vascular endothelial growth factor A (VEGF-A). Curateq ...

During a Case-Based Roundtable® event, Joshua K. Sabari, MD, continued discussion of key outcomes from the MARIPOSA trial and ...